Jaguar Health, Inc. (JAGX) Free cash flow 2016–2025
Jaguar Health, Inc. (JAGX) annual free cash flow history — operating cash flow minus capital expenditures, per SEC filings.
-$23.7MFY2025 · since FY2016: -$14.4M → -$23.7M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$23.7M | — |
| FY2023 | -$33.3M | -0.6% |
| FY2022 | -$33.1M | +5.3% |
| FY2021 | -$35.0M | — |
| FY2019 | -$20.5M | — |
| FY2017 | -$9.9M | +31.2% |
| FY2016 | -$14.4M | — |
Free cash flow = reported operating cash flow − reported capital expenditures for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice
More JAGX financial trends
JAGX RevenueJAGX Net incomeJAGX Net marginJAGX Gross profitJAGX Gross marginJAGX Operating incomeJAGX Operating marginJAGX Operating cash flowJAGX Capital expendituresJAGX Return on equityJAGX Stock buybacksJAGX Dividends paidJAGX Total assetsJAGX Total liabilitiesJAGX Shareholders’ equityJAGX overview →